INTERNATIONAL PATENT: DAIICHI SANKYO COMPANY, LIMITED, MERCK SHARP & DOHME LLC FILES APPLICATION FOR "COMBINATION OF ANTI-B7-H3 ANTIBODY-DRUG CONJUGATE AND ANDROGEN RECEPTOR SIGNALING INHIBITOR"

GENEVA, Nov. 24 -- DAIICHI SANKYO COMPANY, LIMITED (3-5-1, Nihonbashi Honcho, Chuo-kuTokyo, 103-8426), MERCK SHARP & DOHME LLC (126 East Lincoln AvenueRahway, New Jersey 07065) filed a patent application (PCT/IB2025/055075) for "COMBINATION OF ANTI-B7-H3 ANTIBODY-DRUG CONJUGATE AND ANDROGEN RECEPTOR SIGNALING INHIBITOR" on May 15, 2025. With publication no. WO/2025/238587, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HASEGAWA, Jun (c/o DAIICHI SANKYO COMPANY, LIMITED3-5-1 Nihonbashi Honcho, Chuo-kuTokyo, 103-8426), HAT...